Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
An update from Lee’s Pharmaceutical Holdings Limited ( (HK:0950) ) is now available.
Lee’s Pharmaceutical Holdings Limited has convened its annual general meeting for 21 May 2026 in Hong Kong, where shareholders will review and approve the audited financial statements for the year ended 31 December 2025 and consider a final dividend. The agenda also includes the re-election of one executive, one non-executive and one independent non-executive director, approval of directors’ remuneration, re-appointment of the external auditor, and renewal of general mandates for share repurchases and new share issuance, which together shape the company’s capital management and governance framework for the coming year.
More about Lee’s Pharmaceutical Holdings Limited
Lee’s Pharmaceutical Holdings Limited is a Hong Kong–listed company in the healthcare and pharmaceutical sector. The group focuses on developing and commercialising pharmaceutical products, with its operations and corporate governance overseen from its base at Hong Kong Science Park in Shatin.
Average Trading Volume: 709,713
Technical Sentiment Signal: Sell
Current Market Cap: HK$712.5M
See more data about 0950 stock on TipRanks’ Stock Analysis page.